跳至主要内容
临床试验/NCT02285387
NCT02285387Unknown不适用

Rhythm Control of AF in Patients With Acute Stroke

Yonsei University1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2014年11月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
300
试验地点
1
主要终点
acute stroke with AF

研究概览

简要总结

Prospective randomized (rhythm control or rate control) Objective of study

  1. To analyze long term outcome of patients with acute stroke with atrial fibrillation according to the rhythm control
  2. To analyze recurrence rate of atrial fibrillation or recurrence stroke in patients with acute stroke according to the rhythm control (by antiarrhythmic drug, cardioversion, catheter ablation)

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with Atrial fibrillation (20~80 years old)
  • patients with Acute stroke within 7 days
  • LA diameter < 55mm
  • patients possible to anticoagulation and anti arrhythmic drug
  • NIHSS score ≤12

排除标准

  • Hemorrhagic transformation
  • Large cerebral lesion or cerebellar lesion (more than 1/3 of MCA area and 1/2 of ACA area, 1/2 of PCA area, 1/2 of cerebellar area)
  • active internal bleeding
  • Impossible to anticoagulation or anti arrhythmic drug
  • Valvular AF (MA> GII, Mechanical valve, Mitral valve replacement)
  • LV ejection fraction < 30%
  • Structural cardiac disease
  • Catheter ablation history for AF, Cardiac surgery
  • Already prescribed anti arrhythmic drugs
  • With severe medical disease
  • Expected survival < 1year
  • Severe alcoholics, drug addiction
  • 14. Contraindication to MRI

研究组 & 干预措施

Rhythm control group

Experimental
  1. Start AAD right after evaluating for LA size, EF, LA thrombus, and presence of CAD during anticoagulation
  2. Cardioversion after 1 month
  3. Rhythm FU schedule (2012 ACC/AHA/ESC guidelines)
  4. If AF recur, RFCA

干预措施: Rhythm control (Procedure)

Rate control group

Active Comparator
  1. No AAD, just anticoagulation
  2. HR control between 60~110bpm (with beta blocker, calcium channel blocker, digoxin)
  3. Without the treatment about antiarrhythmia and rhythm control, deification of rate control, the subject will be drop out for study.

干预措施: Rate control (Procedure)

结局指标

主要结局

acute stroke with AF

时间窗: 1 year

Long term outcome of rhythm control in patients with acute stroke with AF related to all cause morality, hospital admission, recurrence rate of stroke, major adverse cardiac events

recurrence of silence stroke

时间窗: 1 year

Adverse events after anticoagulation or anti arrhythmic drug, recurrence rate after RFCA on AF in patients with stroke, adverse events after RFCA, recurrence rate of silence stroke or clinical stroke

recurrence of AF after rhythm control

时间窗: 1 year

Adverse events after anticoagulation or anti arrhythmic drug, recurrence rate after RFCA on AF in patients with stroke, adverse events after RFCA, recurrence rate of silence stroke or clinical stroke

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验